Detailed answers about MICHAEL MOKAWEM MEDICAL PRACTICE LIMITED, including incorporation, status, business activity, and accounts information.
When was MICHAEL MOKAWEM MEDICAL PRACTICE LIMITED founded?
MICHAEL MOKAWEM MEDICAL PRACTICE LIMITED was officially incorporated on 4 March 2020 and is registered under company number 12496921. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is MICHAEL MOKAWEM MEDICAL PRACTICE LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of MICHAEL MOKAWEM MEDICAL PRACTICE LIMITED?
MICHAEL MOKAWEM MEDICAL PRACTICE LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does MICHAEL MOKAWEM MEDICAL PRACTICE LIMITED do?
MICHAEL MOKAWEM MEDICAL PRACTICE LIMITED operates in the following sectors: 86101 - Hospital activities, 86900 - Other human health activities. These SIC codes provide insight into the company's business activities and industry focus.
What is MICHAEL MOKAWEM MEDICAL PRACTICE LIMITED's registered address?
The registered office address of MICHAEL MOKAWEM MEDICAL PRACTICE LIMITED is ROYAL NATIONAL ORTHOPAEDIC HOSPITAL, BROCKLEY HILL, STANMORE, MIDDLESEX, UNITED KINGDOM, HA7 4LP. This is the official address filed with Companies House for legal and statutory correspondence.
Is MICHAEL MOKAWEM MEDICAL PRACTICE LIMITED financially stable?
The most recent accounts for MICHAEL MOKAWEM MEDICAL PRACTICE LIMITED were made up to 31 March 2025, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 December 2026.